Pacer Advisors Portfolio holdings
AUM
$39.6B
1-Year Return
5.04%
This Quarter Return
+9.61%
1 Year Return
+5.04%
3 Year Return
+42.86%
5 Year Return
+91.64%
10 Year Return
+332.32%
AUM
$43.5B
AUM Growth
+$8.16B
(+23%)
Cap. Flow
+$3.86B
Cap. Flow
% of AUM
8.88%
Top 10 Holdings %
Top 10 Hldgs %
11.55%
Holding
3,919
New
249
Increased
1,063
Reduced
1,013
Closed
119
Top Buys
| 1 |
Kenvue
KVUE
|
$439M |
| 2 |
AT&T
T
|
$437M |
| 3 |
Cummins
CMI
|
$427M |
| 4 |
Bunge Global
BG
|
$340M |
| 5 |
DaVita
DVA
|
$232M |
Top Sells
| 1 |
Qualcomm
QCOM
|
$453M |
| 2 |
AbbVie
ABBV
|
$447M |
| 3 |
Phillips 66
PSX
|
$441M |
| 4 |
D.R. Horton
DHI
|
$440M |
| 5 |
Booking.com
BKNG
|
$405M |
Sector Composition
| 1 | Consumer Discretionary | 17.42% |
| 2 | Energy | 16.95% |
| 3 | Industrials | 11.93% |
| 4 | Technology | 11.17% |
| 5 | Healthcare | 10.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1376
Digi International
DGII
$1.27B
| $18.7K | ﹤0.01% |
585
+446
| +321% | +$14.2K |
|
1377
CareDx
CDNA
$697M
| $18K | ﹤0.01% |
+1,698
| New | +$18K |
|
1378
Relay Therapeutics
RLAY
$690M
| $17.9K | ﹤0.01% |
+2,157
| New | +$17.9K |
|
1379
Regenxbio
RGNX
$476M
| $17.6K | ﹤0.01% |
+835
| New | +$17.6K |
|
|
CDMO
1380
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $16.4K | ﹤0.01% |
+2,450
| New | +$16.4K |
|
1381
Allogene Therapeutics
ALLO
$246M
| $16.3K | ﹤0.01% |
+3,657
| New | +$16.3K |
|
|
DCPH
1382
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $16K | ﹤0.01% |
+1,016
| New | +$16K |
|
1383
Anavex Life Sciences
AVXL
$804M
| $15.9K | ﹤0.01% |
+3,120
| New | +$15.9K |
|
1384
Olema Pharmaceuticals
OLMA
$436M
| $15.5K | ﹤0.01% |
+1,369
| New | +$15.5K |
|
1385
MannKind Corp
MNKD
$1.64B
| $15.4K | ﹤0.01% |
+3,408
| New | +$15.4K |
|
1386
Day One Biopharmaceuticals
DAWN
$759M
| $14.9K | ﹤0.01% |
+902
| New | +$14.9K |
|
1387
Nurix Therapeutics
NRIX
$697M
| $14.5K | ﹤0.01% |
+985
| New | +$14.5K |
|
1388
InMode
INMD
$911M
| $14K | ﹤0.01% |
650
-24
| -4% | -$519 |
|
1389
Sportradar
SRAD
$9.14B
| $13.5K | ﹤0.01% |
1,162
+176
| +18% | +$2.05K |
|
1390
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $13K | ﹤0.01% |
+660
| New | +$13K |
|
1391
Caribou Biosciences
CRBU
$172M
| $12.9K | ﹤0.01% |
+2,516
| New | +$12.9K |
|
1392
Summit Therapeutics
SMMT
$17.7B
| $12.5K | ﹤0.01% |
+3,029
| New | +$12.5K |
|
1393
Unity
U
$17B
| $12.5K | ﹤0.01% |
468
+86
| +23% | +$2.3K |
|
1394
Qiagen
QGEN
$10.2B
| $11.4K | ﹤0.01% |
259
| – | – |
|
|
EVRI
1395
DELISTED
Everi Holdings
EVRI
| $11.4K | ﹤0.01% |
1,131
+200
| +21% | +$2.01K |
|
1396
Bally's
BALY
$491M
| $11.3K | ﹤0.01% |
814
+191
| +31% | +$2.66K |
|
1397
Rush Street Interactive
RSI
$2.03B
| $10.5K | ﹤0.01% |
1,619
-6
| -0.4% | -$39 |
|
1398
MiMedx Group
MDXG
$1.05B
| $10.3K | ﹤0.01% |
+1,344
| New | +$10.3K |
|
1399
Astria Therapeutics
ATXS
$395M
| $10.3K | ﹤0.01% |
+732
| New | +$10.3K |
|
1400
iShares MSCI Taiwan ETF
EWT
$6.16B
| $10.1K | ﹤0.01% |
208
-54
| -21% | -$2.63K |
|